ACICO Industries Company - K.S.C. (Public) (KWSE:ACICO)

CTI BioPharma Ratios and Metrics

Market cap in millions KWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28	27	26	28	46	30
Market Cap Growth	-4.41%	3.02%	-5.92%	-39.16%	55.37%	-32.90%
Enterprise Value	250	259	291	303	323	314
Last Close Price	0.09	0.08	0.08	0.08	0.14	0.09
PE Ratio	-	-	-	-	223.65	-
PS Ratio	0.42	0.41	0.39	0.37	0.61	0.51
PB Ratio	0.83	0.97	0.68	0.65	0.50	0.32
P/TBV Ratio	4.31	146.48	8.92	4.17	0.95	0.61
P/FCF Ratio	3.94	3.85	2.13	2.31	2.79	7.25
P/OCF Ratio	3.50	3.42	2.03	2.04	2.19	2.56
EV/Sales Ratio	3.74	3.90	4.26	4.03	4.31	5.39
EV/EBITDA Ratio	27.45	26.20	31.43	-	29.92	103.70
EV/EBIT Ratio	57.28	42.21	53.96	-	50.70	-
EV/FCF Ratio	34.94	36.87	23.51	25.10	19.65	77.08
Debt / Equity Ratio	6.81	8.44	6.86	6.05	2.92	2.94
Debt / EBITDA Ratio	24.53	22.13	26.42	-	22.42	61.41
Debt / FCF Ratio	32.46	33.37	21.40	21.67	16.19	66.73
Asset Turnover	0.20	0.20	0.19	0.20	0.19	0.14
Inventory Turnover	2.39	2.31	2.47	3.20	2.22	1.55
Quick Ratio	0.14	0.11	0.11	0.43	0.48	0.39
Current Ratio	0.34	0.35	0.32	1.51	0.93	0.88
Return on Equity (ROE)	-11.85%	-33.62%	-15.03%	-69.04%	0.16%	-27.76%
Return on Assets (ROA)	0.88%	1.14%	0.94%	-1.67%	1.01%	-0.38%
Return on Capital (ROIC)	1.04%	1.36%	1.11%	-1.89%	1.10%	-0.41%
Return on Capital Employed (ROCE)	11.50%	12.40%	8.90%	-	2.00%	-
Earnings Yield	-4.27%	-28.50%	-14.52%	-145.79%	0.45%	-97.19%
FCF Yield	25.38%	26.00%	47.06%	43.25%	35.84%	13.80%
Payout Ratio	-	-	-	-	22.81%	-
Buyback Yield / Dilution	-	-	-	-0.22%	0.05%	0.33%
Total Shareholder Return	-	-	-	-0.22%	0.05%	0.33%

Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.